These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1370225)

  • 1. Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens.
    Reinholdsson-Ljunggren G; Ramqvist T; Ahrlund-Richter L; Dalianis T
    Int J Cancer; 1992 Jan; 50(1):142-6. PubMed ID: 1370225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single peptide derived from the sequence common to polyoma small and middle T-antigen induces immunity against polyoma tumors.
    Ramqvist T; Reinholdsson G; Carlquist M; Bergman T; Dalianis T
    Virology; 1989 Sep; 172(1):359-62. PubMed ID: 2475972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of an immunodominant peptide antigen induce different anti-polyoma tumor responses in two separate mouse strains.
    Reinholdsson-Ljunggren G; Dalianis T
    Int J Cancer; 1992 Jul; 51(6):968-72. PubMed ID: 1322381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyoma T-antigen-derived synthetic peptides induce polyoma-virus-specific macrophage migration inhibition.
    Reinholdsson G; Ramqvist T; Szigeti R; Dalianis T
    Int J Cancer; 1989 Jun; 43(6):1165-8. PubMed ID: 2543648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.
    Wilson CS; Moser JM; Altman JD; Jensen PE; Lukacher AE
    J Immunol; 1999 Apr; 162(7):3933-41. PubMed ID: 10201912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the polyoma virus tumor-specific transplantation antigen (TSTA).
    Dalianis T
    Adv Cancer Res; 1990; 55():57-85. PubMed ID: 1696775
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
    Lukacher AE; Wilson CS
    J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polyomavirus tumor-specific transplantation antigen (TSTA) epitope is situated within the N-terminal amino acid sequence common to middle and small T-antigens.
    Reinholdsson G; Ramqvist T; Brandberg J; Dalianis T
    Virology; 1988 Oct; 166(2):616-9. PubMed ID: 2459846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against the polyoma tumor-specific transplantation antigen (TSTA) with polyoma T-antigens.
    Ramqvist T; Pallas DO; DeAnda J; Ahrlund-Richter L; Reinholdsson G; Roberts TM; Schaffhausen BS; Dalianis T
    Int J Cancer; 1988 Jul; 42(1):123-8. PubMed ID: 2839427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV40 large tumor antigen associated synthetic peptides define native antigenic determinants and induce protective tumor immunity in mice.
    Bright RK; Shearer MH; Kennedy RC
    Mol Immunol; 1994 Oct; 31(14):1077-87. PubMed ID: 7523865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity.
    Berke Z; Palmer S; Bergman T; Wester D; Svedmyr J; Linder S; Jornvall H; Dalianis T
    J Virol; 1996 May; 70(5):3093-7. PubMed ID: 8627788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of H-2Kb-, Db- and Dd-binding peptides derived from amino acid sequences of polyoma virus T antigens.
    Reinholdsson-Ljunggren G; Franksson L; Dalianis T; Ljunggren HG
    Int J Cancer; 1993 Jul; 54(6):992-5. PubMed ID: 8335406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against polyoma virus (PyV) tumors using vaccinia-PyV recombinants: a major tumor-specific transplantation antigen (TSTA) epitope resides within the C-terminal segment of middle-T protein.
    Kieny MP; Gautier C; Tomasetto C; Kuhn I; Hareuveni M; Clertant P; Lathe R
    Int J Cancer; 1990 Jan; 45(1):185-9. PubMed ID: 1688831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH; Bright RK; Lanford RE; Kennedy RC
    Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid vaccination against virally induced tumors.
    Bright RK; Shearer MH; Kennedy RC
    Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus, and other JC virus tumor antigen cross-reactive antibodies of the PAb1601-1636 panel.
    Hess R; Oberbeck J; Grussenmeyer T; Schoeffel-Keller A; Haessler C; Braun DG; Brandner G
    Intervirology; 1994; 37(1):47-52. PubMed ID: 7523331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies specific for the polyoma virus middle-size tumor antigen.
    Walter G; Hutchinson MA; Hunter T; Eckhart W
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4882-6. PubMed ID: 6272281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
    Lukacher AE; Moser JM; Hadley A; Altman JD
    J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of various tumor-specific antigens in polyoma virus-induced tumors.
    Ting CC; Lavrin DH; Takemoto KK; Ting RC; Herberman RB
    Cancer Res; 1972 Jan; 32(1):1-6. PubMed ID: 4332472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.